BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15572055)

  • 1. Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel.
    Gross ER; Nithipatikom K; Hsu AK; Peart JN; Falck JR; Campbell WB; Gross GJ
    J Mol Cell Cardiol; 2004 Dec; 37(6):1245-9. PubMed ID: 15572055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
    Nithipatikom K; Gross ER; Endsley MP; Moore JM; Isbell MA; Falck JR; Campbell WB; Gross GJ
    Circ Res; 2004 Oct; 95(8):e65-71. PubMed ID: 15388642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
    Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
    J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
    Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases.
    Caron N; El Hajjam A; Declèves AE; Joly E; Falck JR; Kramp R
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):683-90. PubMed ID: 15554908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.
    Nithipatikom K; Endsley MP; Moore JM; Isbell MA; Falck JR; Campbell WB; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H500-5. PubMed ID: 16214838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors.
    Wang MH; Brand-Schieber E; Zand BA; Nguyen X; Falck JR; Balu N; Schwartzman ML
    J Pharmacol Exp Ther; 1998 Mar; 284(3):966-73. PubMed ID: 9495856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion.
    Lv X; Wan J; Yang J; Cheng H; Li Y; Ao Y; Peng R
    Eur J Pharmacol; 2008 Oct; 596(1-3):118-26. PubMed ID: 18771665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats.
    Frisbee JC; Roman RJ; Falck JR; Krishna UM; Lombard JH
    Microcirculation; 2001 Feb; 8(1):45-55. PubMed ID: 11296852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
    Gross ER; Hsu AK; Gross GJ
    Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
    Vajda S; Baczkó I; Leprán I
    Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of myocardial infarct size by tetrahydrobiopterin: possible involvement of mitochondrial KATP channels activation through nitric oxide production.
    Wajima T; Shimizu S; Hiroi T; Ishii M; Kiuchi Y
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):243-9. PubMed ID: 16495762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
    Seubert J; Yang B; Bradbury JA; Graves J; Degraff LM; Gabel S; Gooch R; Foley J; Newman J; Mao L; Rockman HA; Hammock BD; Murphy E; Zeldin DC
    Circ Res; 2004 Sep; 95(5):506-14. PubMed ID: 15256482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection following adenosine kinase inhibition in rat hearts.
    Peart JN; Gross GJ
    Basic Res Cardiol; 2005 Jul; 100(4):328-36. PubMed ID: 15795795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epoxygenases belonging to CYP2 family in rat myocardial ischemia/reperfusion injury in vivo.
    Ao Y; Peng RX; Yang J; Wang BH; Falck JR; Dan H; Liu YH
    Saudi Med J; 2008 Jan; 29(1):23-9. PubMed ID: 18176666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation.
    Penna C; Rastaldo R; Mancardi D; Raimondo S; Cappello S; Gattullo D; Losano G; Pagliaro P
    Basic Res Cardiol; 2006 Mar; 101(2):180-9. PubMed ID: 16450075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
    Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system.
    Maslov LN; Lishmanov YB; Oeltgen PR; Barzakh EI; Krylatov AV; Govindaswami M; Brown SA
    Life Sci; 2009 May; 84(19-20):657-63. PubMed ID: 19245818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.
    Gross GJ; Hsu A; Falck JR; Nithipatikom K
    J Mol Cell Cardiol; 2007 Mar; 42(3):687-91. PubMed ID: 17217955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.